Across TCGA pan-cancer cohorts, HMGN2P24 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated HMGN2P24 data layer.
The strongest signal is observed in adrenocortical carcinoma (ACC), where higher HMGN2P24 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated HMGN2P24 expression acts as an unfavorable survival marker, although some lineages such as THCA and COAD show a favorable association.
ACC, THCA, and MESO are the cancer types where HMGN2P24 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.